Background Measurement of intraocular pressure (IOP) plays a central role throughout ophthalmology. It is part of routine ophthalmologic examinations and important in the management and follow-up of patients with glaucoma. While elevated IOP remains the most important risk factor for development and progression of open angle glaucoma, at least half of the population diagnosed with open angle glaucoma is asymptomatic. Objectives The aim of our study is to compare the accuracy of intraocular pressure measurement before and after Laser in situ keratomeulsis (LASIK) surgery using three different types of Tonometers: Goldmann Applanation tonometry (GAT), Non contact tonometry (NCT) and Rebound tonometry (I care), considering the change in the central corneal thickness (CCT). Patients and Methods In this study Eighty eyes of 40 patients with mean age of 27.00±6.00 years were scheduled for LASIK..Central corneal thickness before and after surgery was obtained by Ultrasound (US) pachymetry.IOP values were measured before and after surgery using three different types of Tonometers: Goldmann Applanation tonometry, Non contact tonometry and Rebound tonometry. Results The results revealed that lower post-operative IOP measurements using all techniques. The least affected technique was Non –contact with IOP change 16%, followed by GAT with IOP change 18%, and finally Rebound with IOP change 19 %, respectively. The percentage of change in CCT between pre- and post- LASIK surgery measured with the Ultrasound pachymetry was statistically highly significant. There was a clinical significant correlation between Percentage of tissue ablation (PTA) and IOP change for GAT, NCT and rebound tonometry. Also, there was a significant correlation between Residual stromal bed (RSB) and IOP change for GAT and NCT. There was no clinical significant correlation between Ablation depth (AD) and percentage of change of IOP measurements pre and post LASIK, except for IOP measured with GAT when AD < 40.00 µm. Conclusion Refractive surgery causes significant lowering of IOP as measured using Goldmann applanation tonometry, non contact tonometry and rebound tonometry. The least affected tonometry post LASIK is non contact tonometry. The reduction was correlated to the percentage of tissue ablated. The ideal method to measure IOP in post-LASIK patients would be a device that is free of corneal factors.
Purpose This study aimed at comparing femto-LASIK with small incision lenticule extraction (SMILE) as regards the safety, efficacy, accuracy and post-operative complications with special emphasis on the post-operative dry eye, corneal sensation and corneal biomechanics in cases of myopia and myopic astigmatism. Patients and Methods The study was a prospective comparative study that was conducted in a private eye hospital on 60 eyes of 30 patients with myopia or myopic astimgatism. Each patient was fully assessed preoperatively including visual acuity, refraction, tear breakup time, Schirmer test, corneal sensation & Ocular Response Analyzer®. Femto-LASIK was done to 15 patients and SMILE was done to 15 patients. Postoperative visual acuity, refraction, tear breakup time, Schirmer test, corneal sensation at 1 month, 3 months and 6 months and Ocular Response Analyzer® at 6 months were done and data was retrieved and analyzed. Results Cylindrical error was higher in SMILE group at all postoperative points. Tear breakup time was better in SMILE group in 1st month, but no significant difference in later follow ups. Corneal sensation was better in SMILE group in 1 month and 3 months, but this difference disappeared at 6 months. Corneal hysteresis & corneal resistance factor were significantly better in SMILE group. Conclusion Both techniques are safe and efficient. Femto-LASIK is more efficient in correcting cylindrical error. SMILE is better in early postoperative dry eye, corneal sensation and in corneal biomechanics.
Background Neo-vascular age-related macular degeneration (nAMD) (an advanced form of macular degeneration) is the main cause of visual impairment in older adults related to AMD. WHO has estimated that approximately 8 million people will be affected by AMD by the year 2020. Optical coherence tomography angiography (OCTA) is a novel imaging modality that permits direct visualization of the retinal and choroidal vasculature in vivo. In OCTA, high-frequency and dense volumetric scanning are made to detect blood flow by analyzing the signal decorrelation between scans. Compared with stationary areas of the retina, the movement of erythrocytes within a vessel makes a decorrelated signal. Unlike traditional angiography, OCTA does not necessitate the use of exogenous dyes, so avoiding potential side effects, such as nausea or other more serious adverse events. However, the role of OCTA as a diagnostic tool has not been largely investigated. Particularly, very few clinical studies have assessed the accuracy of OCTA imaging for the diagnosis of nAMD. Aim of the Work To highlight the benefits of using OCT-A in the diagnosis and management of wet AMD and compare it with the conventional angiographic standard, fundus fluorescein angiography (FFA). Subjects and Methods An interventional prospective comparative study will be conducted on 40 eyes diagnosed with wet AMD. Optical coherence tomography angiography and FFA will be done for all eyes. Analysis of the data obtained from the OCT-A will be done and compared with the standard FFA. Conclusion AMD is the leading cause of vision loss. Early detection and treatment is required. AMD is diagnosed by fundus examination, FA, and OCTA. OCTA and FA imaging provide complementary information about pathological changes in chorioretinal diseases. OCTA is highly sensitive for identifying AMD, CNV, and CNV activity; however, it cannot fully replace FA in the diagnosis of AMD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.